About Renerva
Renerva is a company based in Pittsburgh (United States) founded in 2017 by Lorenzo Soletti.. Renerva has raised $1.28 million across 8 funding rounds from investors including NIH, HHS and America’s Seed Fund. Renerva offers products and services including Implantable Technologies. Renerva operates in a competitive market with competitors including Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others.
- Headquarter Pittsburgh, United States
- Founders Lorenzo Soletti
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Renerva Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.28 M (USD)
in 8 rounds
-
Latest Funding Round
$324.82 K (USD), Seed
Sep 15, 2025
-
Investors
NIH
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renerva
Renerva offers a comprehensive portfolio of products and services, including Implantable Technologies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for improving peripheral nerve repair outcomes
Unlock access to complete
Unlock access to complete
Funding Insights of Renerva
Renerva has successfully raised a total of $1.28M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $324.82 thousand completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Seed — $324,820
-
First Round
First Round
(17 Jun 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Seed - Renerva | Valuation |
investors |
|
| Sep, 2024 | Amount | Grant - Renerva | Valuation |
investors |
|
| Jul, 2024 | Amount | Seed - Renerva | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Renerva
Renerva has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Renerva
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Renerva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Renerva Comparisons
Competitors of Renerva
Renerva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| domain | founded_year | HQ Location |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| domain | founded_year | HQ Location |
Wearable prostheses for sensory peripheral neuropathy patients are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| domain | founded_year | HQ Location |
Developer of bioimplant for peripheral nerve repair
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Renerva
Frequently Asked Questions about Renerva
When was Renerva founded?
Renerva was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Renerva located?
Renerva is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Who is the current CEO of Renerva?
Lorenzo Soletti is the current CEO of Renerva. They have also founded this company.
Is Renerva a funded company?
Renerva is a funded company, having raised a total of $1.28M across 8 funding rounds to date. The company's 1st funding round was a Seed of $335K, raised on Jun 17, 2018.
What does Renerva do?
Renerva was founded in 2017 and is based in Pittsburgh, United States. Focus is placed on the medical device sector, where implants are developed for peripheral nerve repair procedures. These implants address nerve injuries and aim to enhance nerve function. Operations involve research and development in regenerative medicine, with activities centered on therapeutic solutions for peripheral nervous system conditions.
Who are the top competitors of Renerva?
Renerva's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
What products or services does Renerva offer?
Renerva offers Implantable Technologies.
Who are Renerva's investors?
Renerva has 4 investors. Key investors include NIH, HHS, America’s Seed Fund, and U.S. Department of Defense.